8 things to know about hepatitis C
There's a good reason why hepatitis C is known as a "silent killer."
Jul 20, 2021
0
3
There's a good reason why hepatitis C is known as a "silent killer."
Jul 20, 2021
0
3
A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays. The research team suggested the strategy for virtual screening ...
Jul 8, 2021
0
22
Newly published research shows that a screening program in the University of Cincinnati Medical Center Emergency Department helped detect an outbreak of HIV among persons who inject drugs in Hamilton County, Ohio, from 2014-18.
Jun 30, 2021
0
6
The current system of only screening risk groups for hepatitis B is failing a third of people living with the chronic disease in Australia, according to the authors of a Perspective published today by the Medical Journal ...
Jun 14, 2021
0
3
Mass screening of school age children has led to significantly higher numbers of coeliac disease cases being diagnosed, according to a new study presented today at the 6th World Congress of Paediatric Gastroenterology, Hepatology ...
Jun 5, 2021
0
13
Cystic fibrosis is a genetic, progressive disease that causes persistent lung infections and impacts the most basic physical processes. While recent breakthroughs have significantly extended the lifespan of patients with ...
Jun 4, 2021
0
2
Screening for colorectal cancer—the second most common cause of cancer-related death in the United States—can save lives by detecting both pre-cancerous lesions that can be removed during the screening procedure, and ...
May 20, 2021
0
10
Patients with one or more health conditions are more likely to be screened for colorectal cancer than those without comorbidities, according to new research in the Journal of Osteopathic Medicine. However, patients with five ...
May 3, 2021
0
3
(HealthDay)—Few cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections have been reported at skilled nursing facilities (SNFs) among those with at least 14 days since receipt of the second dose ...
Apr 23, 2021
0
2
Intestinal epithelial tight junctions (TJs) act as a functional and structural barrier against harmful antigens that promote intestinal inflammation in inflammatory bowel disease (IBD) and other inflammatory conditions of ...
Apr 20, 2021
0
5